Latest Mass Tort News and Updates

Last week, the U.S. Food and Drug Administration (FDA) issued a letter to Bayer indicating requirements for submitting adverse event reports and postmarket activities associated with …

Just when Xarelto plaintiff attorneys were rejoicing and preparing on the lines of the first Philadelphia Xarelto trial which brought in the first-ever win for the…

A request has been put before the New Jersey Supreme Court by both parties of Abilify litigation for the creation of a Multicounty Litigation (MCL) to ensure that future…

The Johnson & Johnson’s Talcum powder case in which the verdict of $72 million was dismissed in October 2017 was put forth for an appeal by the family of the plaintiff, an Alabama woman who developed ovarian cancer due to the long-term use of…

Invokana, (a diabetic medication and  SGLT2 inhibitor) was also in the news as the FDA now requires a serious boxed warning to be highlighted in the labels about the increased risk of leg and foot amputations. This…

Despite winning its first trial in November 2017, Testim gel makers, Auxilium, settled a lawsuit for an undisclosed amount, just days before the trial in Pennsylvania’s Philadelphia Court of Common Pleas. Allegations put forth by the…

Portola Pharmaceuticals received news of a second-time delay from the U.S. Food & Drug Administration (FDA) regarding the approval of AndexXa, an antidote developed to monitor uncontrollable bleeding linked to Xarelto and Eliquis.…

The FDA has shown no signs or indications regarding any ban on transvaginal mesh devices used to treat pelvic organ prolapse (POP) and stress urinary…

Eli Lilly and Company, the maker of Axiron used in the treatment of low testosterone levels is one of the defendants in the over 6,000 centralized …

Bayer received good news beginning of the year as the Missouri Supreme Court ruled in its favor regarding an Essure Lawsuit filed by 92 women for injuries allegedly caused…